Wilson CG - Search Results

1

Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit.

Barrow L, Steed KP, Spiller RC, Watts PJ, Melia CD, Davies MC, Wilson CG. Barrow L, et al. Among authors: wilson cg. Gastroenterology. 1992 Oct;103(4):1167-73. doi: 10.1016/0016-5085(92)91500-4. Gastroenterology. 1992. PMID: 1397874

2

Proximal colonic response and gastrointestinal transit after high and low fat meals.

Steed KP, Bohemen EK, Lamont GM, Evans DF, Wilson CG, Spiller RC. Steed KP, et al. Among authors: wilson cg. Dig Dis Sci. 1993 Oct;38(10):1793-800. doi: 10.1007/BF01296101. Dig Dis Sci. 1993. PMID: 8404399

3

Mebeverine decreases mass movements and stool frequency in lactulose-induced diarrhoea.

Washington N, Ridley P, Thomas C, Spiller RC, Watts PJ, Wilson CG. Washington N, et al. Among authors: wilson cg. Aliment Pharmacol Ther. 1998 Jun;12(6):583-8. doi: 10.1046/j.1365-2036.1998.00340.x. Aliment Pharmacol Ther. 1998. PMID: 9678820 Clinical Trial.

4

Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations.

Hebden JM, Gilchrist PJ, Blackshaw E, Frier ME, Perkins AC, Wilson CG, Spiller RC. Hebden JM, et al. Among authors: wilson cg. Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1379-85. doi: 10.1097/00042737-199912000-00007. Eur J Gastroenterol Hepatol. 1999. PMID: 10654798 Clinical Trial.

5

Quantitative, noninvasive assessment of antidiarrheal actions of codeine using an experimental model of diarrhea in man.

Barrow L, Steed KP, Spiller RC, Maskell NA, Brown JK, Watts PJ, Melia CD, Davies MC, Wilson CG. Barrow L, et al. Among authors: wilson cg. Dig Dis Sci. 1993 Jun;38(6):996-1003. doi: 10.1007/BF01295712. Dig Dis Sci. 1993. PMID: 8389688 Clinical Trial.

6

Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine.

Hebden JM, Gilchrist PJ, Perkins AC, Wilson CG, Spiller RC. Hebden JM, et al. Among authors: wilson cg. Pharm Res. 1999 Aug;16(8):1254-9. doi: 10.1023/a:1014805815499. Pharm Res. 1999. PMID: 10468028 Clinical Trial.

7

Limited exposure of the healthy distal colon to orally-dosed formulation is further exaggerated in active left-sided ulcerative colitis.

Hebden JM, Blackshaw PE, Perkins AC, Wilson CG, Spiller RC. Hebden JM, et al. Among authors: wilson cg. Aliment Pharmacol Ther. 2000 Feb;14(2):155-61. doi: 10.1046/j.1365-2036.2000.00697.x. Aliment Pharmacol Ther. 2000. PMID: 10651655 Clinical Trial.

8

Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Hebden JM, Wilson CG, Spiller RC, Gilchrist PJ, Blackshaw E, Frier ME, Perkins AC. Hebden JM, et al. Among authors: wilson cg. Pharm Res. 1999 Jul;16(7):1087-92. doi: 10.1023/a:1018948102778. Pharm Res. 1999. PMID: 10450935

9

Impaired oesophageal transit of capsule versus tablet formulations in the elderly.

Perkins AC, Wilson CG, Blackshaw PE, Vincent RM, Dansereau RJ, Juhlin KD, Bekker PJ, Spiller RC. Perkins AC, et al. Among authors: wilson cg. Gut. 1994 Oct;35(10):1363-7. doi: 10.1136/gut.35.10.1363. Gut. 1994. PMID: 7959187 Free PMC article. Clinical Trial.

10

Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations.

Perkins AC, Wilson CG, Frier M, Vincent RM, Blackshaw PE, Dansereau RJ, Juhlin KD, Bekker PJ, Spiller RC. Perkins AC, et al. Among authors: wilson cg. Int J Pharm. 1999 Sep 20;186(2):169-75. doi: 10.1016/s0378-5173(99)00172-6. Int J Pharm. 1999. PMID: 10486435 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters